31 Dec 2016 Date | | - Cons. EPS | 0 EPS |
30 Sep 2016 Date | | - Cons. EPS | - EPS |
30 Jun 2016 Date | | - Cons. EPS | - EPS |
31 Mar 2016 Date | | - Cons. EPS | - EPS |
31 Dec 2015 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | 0 EPS |
30 Sep 2016 Date | | - Cons. EPS | - EPS |
30 Jun 2016 Date | | - Cons. EPS | - EPS |
31 Mar 2016 Date | | - Cons. EPS | - EPS |
31 Dec 2015 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Simon Yu M.B.A. CEO | OTCQB Exchange | US13765M1099 ISIN |
US Country | 30 Employees | - Last Dividend | 29 Apr 2015 Last Split | - IPO Date |
Cannabis Strategic Ventures is a company deeply entrenched in the cannabis industry within the United States. With its operations based out of Los Angeles, California, the company focuses primarily on the cultivation of marijuana products. Beyond cultivation, Cannabis Strategic Ventures is committed to incubating, developing, and forming partnerships within the cannabis sector and its ancillary services. This multifaceted approach positions the company as a key player in the rapidly evolving cannabis industry, driving innovation and growth through strategic partnerships and development efforts.